Ferguson Merleinsider trades
In SEC Form 4 filings, Ferguson Merle is listed as Director of Bioforce Nanosciences Holdings, Inc. (BFNH). Ferguson Merle reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 2.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| BFNHBioforce Nanosciences Holdings, Inc. | Director | 3 | Sep 2 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-02
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| BFNHBioforce Nanosciences Holdings, Inc. | Apr 22 | Sep 2 | S | 26,700,000 | $0.02 | Sale −$400,500 | not reported | No | Form 4 |
| BFNHBioforce Nanosciences Holdings, Inc. | Apr 20 | Sep 2 | G | 20,580,000 | $0.01 | $144,060 | 22,568,000 | No | Form 4 |
| BFNHBioforce Nanosciences Holdings, Inc. | Apr 20 | Sep 2 | G | 4,132,000 | $0.00 | $4,132 | 26,700,000 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.